Cargando…

p53, a novel regulator of lipid metabolism pathways

Detalles Bibliográficos
Autores principales:	Goldstein, Ido, Ezra, Osnat, Rivlin, Noa, Molchadsky, Alina, Madar, Shalom, Goldfinger, Naomi, Rotter, Varda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374261/ http://dx.doi.org/10.1186/1753-6561-6-S3-P61

Ejemplares similares

Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells
por: Sarig, Rachel, et al.
Publicado: (2010)

p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production
por: Goldstein, Ido, et al.
Publicado: (2013)

Modulated expression of WFDC1 during carcinogenesis and cellular senescence
por: Madar, Shalom, et al.
Publicado: (2009)

Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner
por: Charni-Natan, Meital, et al.
Publicado: (2018)

Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon Beta
por: Madar, Shalom, et al.
Publicado: (2013)

p53 on the crossroad between regeneration and cancer
por: Charni, Meital, et al.
Publicado: (2017)

p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner
por: Molchadsky, Alina, et al.
Publicado: (2008)

Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells
por: Grespi, Francesca, et al.
Publicado: (2016)

Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation
por: Charni, M, et al.
Publicado: (2016)

p53-repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation
por: Brosh, Ran, et al.
Publicado: (2008)

Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers
por: Solomon, Hilla, et al.
Publicado: (2018)

Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
por: Tal, Perry, et al.
Publicado: (2016)

Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
por: Tal, Perry, et al.
Publicado: (2019)

Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy
por: Lonetto, Giuseppe, et al.
Publicado: (2018)

TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model
por: Leshem, Orit, et al.
Publicado: (2011)

A Novel Translocation Breakpoint within the BPTF Gene Is Associated with a Pre-Malignant Phenotype
por: Buganim, Yosef, et al.
Publicado: (2010)

Mutant p53 exerts its gain of function through activation of the NF-κB pathway
por: Damalas, A, et al.
Publicado: (2005)

D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010)

The in vivo function of TIGAR, a p53 target gene that regulates glucose metabolism
por: Cheung, Eric, et al.
Publicado: (2014)

Targeting mutant p53 for cancer therapy
por: Oren, Moshe, et al.
Publicado: (2016)

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
por: Aoubala, M
Publicado: (2008)

p53β isoform modulates differentially p53 transcriptional activity in response to stress
por: Fernandes, K, et al.
Publicado: (2008)

p53 balances between tissue hierarchy and anarchy
por: Koifman, Gabriela, et al.
Publicado: (2019)

Modelling Lipid Metabolism to Improve Healthy Ageing
por: Mc Auley, Mark, et al.
Publicado: (2005)

Corrigendum to ‘p53 balances between tissue hierarchy and anarchy’
por: Koifman, Gabriela, et al.
Publicado: (2019)

Impact of low-lipid environment on de novo lipid synthesis pathways in cancer cells
por: Zaidi, Nousheen
Publicado: (2015)

Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
por: Stein, Yan, et al.
Publicado: (2019)

p53 and the Viral Connection: Back into the Future ‡
por: Aloni-Grinstein, Ronit, et al.
Publicado: (2018)

The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation
por: Harrod, Robert, et al.
Publicado: (2015)

Mutant p53—a potential player in shaping the tumor–stroma crosstalk
por: Stein, Yan, et al.
Publicado: (2019)

The in vivo function of the p53 target gene TIGAR
por: Cheung, Eric C, et al.
Publicado: (2012)

Lipid metabolism in critically ill patients: a microdialysis study
por: Theodorakopoulou, M, et al.
Publicado: (2011)

P53 - Smoking during pregnancy and asthma’s manifestation in childhood
por: Maggina, Paraskevi, et al.
Publicado: (2014)

Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in the Li-Fraumeni Syndrome model, Trp53(+/-) mice
por: Blackburn, Anneke C, et al.
Publicado: (2014)

Total antioxidant status and lipid metabolism in patients with severe multiple trauma
por: Muravyeva, M, et al.
Publicado: (2008)

Prognostic implications of serum lipid metabolism over time during sepsis
por: Lee, SH, et al.
Publicado: (2015)

P05.53. Variations in the implementation and characteristics of chiropractic services in VA
por: Lisi, A, et al.
Publicado: (2012)

Lipid metabolism and organ dysfunction in septic patients during intensive glycemic control
por: Cappi, S, et al.
Publicado: (2007)

P02.53. Examination of the association of diet on persistent cancer related fatigue
por: Zick, S, et al.
Publicado: (2012)

PReS-FINAL-2018: The P53 gene polymorphisms and juvenile idiopathic arthritis
por: Kozhevnikov, A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_eoh4gab5iooipv3bbd8ag6h2q5